Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
On this page:OverviewPublicationsKey papers
ScholarIQanswers from OpenAlex & ORCID

Christopher Lübker

ResearcherPublications, citations & collaboration network

Christopher Lübker is a researcher indexed in ScholarIQ from OpenAlex & ORCID. ScholarIQ records 21 works, 246 citations, an h-index of 6 and an i10-index of 6.

21
Works
246
Citations
6
h-index
6
i10-index

How has Christopher Lübker's publication output changed over time?

ScholarIQpublication output · 2022–2025

Output grew200% over the shown period — from 1 works in 2022 to 3 in 2025.

1
3
3
3
2022202320242025

What are the most-cited papers on Christopher Lübker?

ScholarIQmost cited works
Educational inequalities in longevity among OECD countries around 2016
Fabrice Murtin, Christopher Lübker
OECD papers on well-being and inequalities. 2022139 CitationsOPEN ACCESS
Once-Weekly Subcutaneous Semaglutide 2.4 mg Injection is Cost-Effective for Weight Management in the United Kingdom
Hera Sandhu, Weiwei Xu, Anamaria‐Vera Olivieri, Christopher Lübker, Inger Smith, Vasileios Antavalis
Advances in Therapy. 202325 CitationsOPEN ACCESS
Cost-effectiveness of semaglutide in people with obesity and cardiovascular disease without diabetes
Phil McEwan, Martin Bøg, Mads Faurby, V. Foos, Ildiko Lingvay, Christopher Lübker, Ryan Miller, Joshua C. Toliver, Florian Yeates, A. Michael Lincoff
Journal of Medical Economics. 202519 CitationsOPEN ACCESS
Changes in longevity inequality by education among OECD countries before the COVID-19 pandemic
Christopher Lübker, Fabrice Murtin
BMC Public Health. 202315 CitationsOPEN ACCESS
The association between body mass index and health‐related quality of life in the 2017 and 2018 health survey of England data: A cross‐sectional observational analysis
Xiao Wen Luah, Thomas Holst‐Hansen, Christopher Lübker
Diabetes Obesity and Metabolism. 202414 CitationsOPEN ACCESS

Related on ScholarIQ

Novo Nordisk (Denmark)
Institution
Educational inequalities in longevity among OECD countries around 2016
Paper
Once-Weekly Subcutaneous Semaglutide 2.4 mg Injection is Cost-Effective for Weight Management in the United Kingdom
Paper
Cost-effectiveness of semaglutide in people with obesity and cardiovascular disease without diabetes
Paper
Changes in longevity inequality by education among OECD countries before the COVID-19 pandemic
Paper
The association between body mass index and health‐related quality of life in the 2017 and 2018 health survey of England data: A cross‐sectional observational analysis
Paper
470M+ articles · free account